lonoctocog alpha
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Description:
lonoctocog alpha is a recombinant and single-chain antihemophilic factor approved for the treatment of bleeding episodes in patients with hemophilia A. Main indications are to reduce the number of bleeding episodes and to lower the risk of joint damage due to bleeding.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
antihemophilic factor (recombinant, single-chain), bleeding episodes
Synonyms:
Afstyla
MSDS:
Inquire
Application:
the treatment of bleeding episodes in patients with hemophilia A
Current Developer:
CSL Behring
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Quick Inquiry

Verification code

Featured Items